Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: Relationship to immunophenotype and ploidy

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2169-2177

  Zhang, Long ^a   Taub, Jeffrey W ^a,b,c   Williamson, Michael ^a   Wong, So C ^a   Hukku, Bharati ^b   Pullen, Jeannette ^c   Ravindranath, Y ^a,b,c   Matherly, Larry H ^a,d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^c Pediatric Oncology Group   (United States)

^d KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; FOLIC ACID; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; DIPLOIDY; DISEASE ASSOCIATION; DRUG UPTAKE; GENE EXPRESSION; HUMAN; IMMUNOBLOTTING; IMMUNOPHENOTYPING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; STEM CELL;

ADOLESCENT; AMINO ACID SEQUENCE; ANTIMETABOLITES, ANTINEOPLASTIC; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; INFANT; K562 CELLS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, PRE-B-CELL; LEUKEMIA, T-CELL; MALE; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; METHOTREXATE; MOLECULAR SEQUENCE DATA; PLOIDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0031669954     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Goldman, I. D., and Matherly, L. H. The cellular pharmacology of methotrexate. Pharmacol. Ther., 28: 77-102, 1985.
2. Sirotnak, F. M. Obligate genetic expression in tumor cells of a fetal membrane property mediating "folate" transport: biological significance and implications of improved therapy of human cancer. Cancer Res., 45: 3992-4000, 1985.
3. Sirotnak, F. M., Moccio, D. M., Kelleher, L. E., and Goutas, L. J. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate resistant L1210 clonal lines derived in vivo. Cancer Res., 41: 4447-4452, 1981.
4. Matherly, L. H., and Taub, J. W. Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia. Leukemia Lymphoma, 21: 359-368, 1996.
5. Poplack, D. G. Acute lymphoblastic leukemia. In: P. A. Pizza and D. G. Poplack (eds.), Principles and Practice of Pediatric Oncology, pp. 431-481. Philadelphia: J. B. Lippincott Co., 1993.
6. Matherly, L. H., Taub, J. W., Wong, S. C., Simpson, P. M., Ekizian, E., Buck, S., Williamson, M., Amylon, M., Pullen, J., Camilla, B., and Ravindranath, Y. Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children. Blood, 90: 578-589, 1997.
7. Trippelt, T., Schlemmer, S., Elisseyeff, Y., Goker, E., Wachter, M., Steinherz, P., Tan, C., Berman, E., Wright, J. E., Rosowsky, A., Schwitzer, B., and Bertino, J. R. Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia. Blood, 80: 1158-1162, 1992.
8. Gorlick, R., Goker, E., Trippett, T., Steinherz, P., Elisseyeff, Y., Mazumdar, M., Flintoff, W. F., and Bertino, J. R. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphoblastic leukemia and is associated with decreased reduced folate carrier expression. Blood, 89: 1013-1018, 1997.
9. Horikoski, T., Danenberg, K. D, Stadlbauer, T. H. W., Volkenandt, M., Shea, L. C. C., Aigner, K., Gustavsson, B., Leichman, L., Frosing, R., Ray, M., Gibson, N. W., Spears, C. P., and Danenberg, P. V. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res., 52: 108-116, 1992.
10. Lenz, H. J., Danenberg, K., Schnieders, B., Goker, E., Peters, G. J., Garrow, T., Shane, B., Bertino, J. R., and Danenberg, P. V. Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients. Oncol. Res., 6: 329-335, 1994.
11. Noonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., and Roninson, I. B. Quantitative analysis of MDR1 (mullidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87: 7160-7164, 1990.
12. Synold, T. W., Relling, M. V., Boyett, J. M., Rivera, G. K., Sandlund, J. T., Mahmoud, H., Crist, W. M., Pui, C. H., and Evans, W. E. Blast cell methotrexate polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J. Clin. Invest., 94: 1996-2001, 1994.
13. Whitehead, V. M., Vuchich, M. J., Lauer, S. J., Mahoney, D., Carroll, A. J., Shuster, J. J., Esseltine, D. W., Payment, C., Look, A. T., Akabutu, J., Bowen, T., Taylor, L. D., Camitta, B., and Pullen, D. J. Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (>50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Blood, 80: 1316-1323, 1992.
14. Whitehead, V. M., Vuchich, M. J., Carroll, A. J., Lauer, S. J., Mahoney, D., Shuster, J. J., Payment, C., Koch, P. A., Akabutu, J. J., Bowen, T., Kamen, B. A., Ravindranath, Y., Emami, A., Beardsley, G. P., Pullen, D. J., and Camitta, B. Accumulation of methotrexate polyglutamates (MTXPGS) in lymphoblasts, ploidy and trisomy of both chromosomes 4 and 10 in childhood B-progenitor cell acute lymphoblastic leukemia (ALL): a Pediatric Oncology Group study. Blood, 84: 515a, 1994.
15. Fry, D. W., Yalowich, J. C., and Goldman, I. D. Rapid formation of polyglutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cells. J. Biol. Chem., 257: 1890-1896, 1982.
16. Matherly, L. H., Angeles, S. M., and Czajkowski, C. A. Characterization of transport-mediated methotrexate resistance in cultured human tumor cells with antibodies to the membrane carrier for methotrexate and tetrahydrofolate cofactors. J. Biol. Chem., 267: 23253-23260, 1992.
17. Wong, S. C., Proefke, S. A, Bhushan, A., and Matherly, L. H. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport defective Chinese hamster ovary cells. J. Biol. Chem., 279: 17468-17457, 1995.
18. Duch, D. S., Banks, S., Dev, I. K., Dickerson, S. H., Ferone, R., Heath, L. S., Humphreys, J., Knick, V., Pendergest, W., Singer, S., Smith, G. K., Waters, K., and Wilson, H. R. Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase. Cancer Res., 53: 810-818, 1993.
19. Wong, S. C., Zhang, L., Proefke, S. A., Hukku, B., and Matherly, L. H. Gene amplification and increased expression of the reduced folate carrier in transport elevated K562 cells. Biochem. Pharmacol., 55: 1135-1138, 1998.
20. Harlowe, E., and Lane, D. (eds.). Protocols for immunoaffinity purification. In: Antibodies: A Laboratory Manual, p. 310. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
21. Siebert, P. D., and Larrick, J. W. Competitive PCR. Nature (Lond.), 359: 557-558, 1992.
22. Johnson, P. G., Lenz, H. J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., and Leichman, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55: 1407-1412, 1995.
23. Matherly, L. H., Taub, J. W., Ravindranath, Y., Proefke, S. A., Wong, S. C., Gimotty, P., Buck, S., Wright, J. E., and Rosowsky, A. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphocytic leukemia. Blood, 85: 500-509, 1995.
24. Becker-Andre, M., and Hahlbrock, K. Absolute mRNA quantitation using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY). Nucleic Acids Res., 17: 9437-9446, 1989.
25. Gilliland, G., Perrin, S., Blanchard, K., and Bunn, H. F. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87: 2725-2729, 1990.
26. Moscow, J. A., Connolly, T., Myers, T. G., Cheng, C. C., Paul, K., and Cowan, K. H. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines. Int. J. Cancer, 72: 184-190, 1997.
27. Brigle, K. E., Spinella, M. J., Sierra, E. E., and Goldman, I. D. Characterization of a mutation in the reduced folate carrier in a transport defective L1210 murine cell line. J. Biol. Chem., 270: 22974-22979, 1995.
28. Wong, S. C., Proefke, S. A., and Matherly, L. H. Mutations in the reduced folate carrier in transport-impaired CCRF-CEM cells. Proc. Am. Assoc. Cancer Res., 38: 162, 1997.
29. Gong, M., Yess, J., Connolly, T., Percy Ivy, S. P., Ohnuma, T., Cowan, K. H., and Moscow, J. A. Molecular mechanism of antifolate transport-deficiency in a methotrexate resistant MOLT-3 human leukemia cell line. Blood, 89: 2494-2499, 1997.
30. Trueworthy, R., Shuster, J., Look, T., Crist, W., Borowitz, M., Carroll, A., Frankel, L., Harris, M., Wagner, H., Haggard, M., Mosijczuk, A., Pullen, J., Steuber, P., and Land, V. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia in childhood: a Pediatric Oncology Group study. J. Clin. Oncol., 10: 606-613, 1992.
31. Moscow, J. A., Gong, M., He, R., Sgagias, M. K., Dixon, K. H., Anzick, S. L., Meltzer, P. S., and Cowan, K. H. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate resistant human breast cancer cells. Cancer Res., 55: 3790-3794, 1995.
32. Raimondi, S. C., Pui, C. H., Hancock, M. L., Behm, F. G., Filatov, L., and Rivera, G. K. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia. Leukemia (Baltimore), 10: 213-224, 1996.
33. Raimondi, S. C., Pui, C. H., Head, D., Behm, F., Privitera, E., Roberson, P. K., Rivera, G. K., and Williams, D. L. Trisomy 21 as the sole acquired chromosomal abnormality in children with acute lymphoblastic leukemia. Leukemia (Baltimore), 6: 171-175, 1992.
34. Peeters, M., and Poon, A. Down syndrome and leukaemia: unusual clinical aspects and unexpected methotrexate sensitivity. Eur. J. Pediatr., 146: 416-422, 1987.